Optimizing Target Selection and Development Strategy in Cancer Treatment; The Next Wave

E-ISSN： 1875-5968|4|5|445-447

ISSN： 1568-0118

Source： Current Medicinal Chemistry - Anti-Cancer Agents, Vol.4, Iss.5, 2004-09, pp. : 445-447

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Optimizing Treatment for Cervical Cancer: The Value of Chemoradiation

By John A. Green

American Journal of Cancer, Vol. 3, Iss. 4, 2004-01 ,pp. : 215-227

Adis International

Access to resources Recommend Favorite

Optimizing treatment of the partially platinum-sensitive ovarian cancer patient

By Colombo Nicoletta

Future Oncology, Vol. 9, Iss. 12, 2013-12 ,pp. : 19-23

Future Medicine

Access to resources Recommend Favorite

Optimizing ixabepilone treatment schedules in patients with advanced or metastatic breast cancer

By Egerton Nancy

Cancer Chemotherapy and Pharmacology, Vol. 66, Iss. 6, 2010-11 ,pp. : 1005-1012

Springer Publishing Company

Access to resources Recommend Favorite

HOTAIR is a potential target for the treatment of cisplatinresistant ovarian cancer

By Wang Yu Wang Hongli Song Tiefang Zou Yiting Jiang Jing Fang Lei Li Peiling

Molecular Medicine Reports, Vol. 12, Iss. 2, 2015-08 ,pp. : 2211-2216

Spandidos Publications

Access to resources Recommend Favorite

The Proteasome as a Target for Cancer Treatment: Focus on Bortezomib

By Papandreou Christos N.

American Journal of Cancer, Vol. 4, Iss. 6, 2005-01 ,pp. : 359-372

Adis International

Access to resources Recommend Favorite